Condition
Postmenopausal Osteoporosis clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Postmenopausal Osteoporosis clinical trials that are recruiting, at sites in 4 countries (most in Turkey (Türkiye) (1), France (1), United States (1)). By phase: Phase 4 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Postmenopausal Osteoporosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis | — | Küçükçekmece, Istanbul | Recruiting | Jun 30, 2026 |
| Ibandronate vs. Zoledronic Acid After Denosumab: Is Either Equal for Postmenopausal Osteoporosis? | Phase 4 | Taipei | Recruiting | Feb 12, 2026 |
| Blackcurrant supplementation to test bone density changes in postmenopausal women | Phase 1 | Storrs, Connecticut | Recruiting | Jan 26, 2026 |
| Zoledronate options after stopping denosumab in postmenopausal osteoporosis. | Phase 4 | Amiens and 16 other locations | Recruiting | Jan 9, 2025 |
All recruiting trials (4)
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Ibandronate vs. Zoledronic Acid After Denosumab: Is Either Equal for Postmenopausal Osteoporosis?
In postmenopausal osteoporosis, this study tests whether intravenous ibandronate given after stopping denosumab works as well as zoledronic acid over a year.
-
Blackcurrant supplementation to test bone density changes in postmenopausal women
This study tests whether taking blackcurrant extract can help improve bone density in postmenopausal women by affecting the gut microbiome.
-
Zoledronate options after stopping denosumab in postmenopausal osteoporosis.
This trial will test whether using a blood bone‑turnover marker to decide on extra zoledronate infusions better prevents spinal bone loss in postmenopausal women who stop denosumab.
Related topics
Quick answers
How many Postmenopausal Osteoporosis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Turkey (Türkiye) (1 trial), France (1 trial), United States (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.